)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Monte Rosa Therapeutic
Monte Rosa Therapeutic (GLUE) investor relations material
Monte Rosa Therapeutic Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Executive summary
Annual meeting scheduled for June 11, 2026, to be held virtually for shareholders of record as of April 16, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by June 1, 2026.
Voting matters and shareholder proposals
Shareholders will vote to elect three Class II director nominees to serve until the 2029 annual meeting or until successors are elected.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is on the agenda.
Additional business may be transacted if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Director nominees for election are Andrew Schiff, M.D., Chandra P. Leo, M.D., and Anthony Manning, Ph.D.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Monte Rosa Therapeutic
- Shareholders will elect directors, ratify Deloitte as auditor, and review governance and compensation.GLUE
Proxy filing29 Apr 2026 - Major data updates and new phase II trials are expected in 2024 for key molecular glue programs.GLUEBarclays 28th Annual Global Healthcare Conference26 Mar 2026
- Advancing highly selective oral degraders for major unmet needs in immunology and oncology.GLUECorporate presentation17 Mar 2026
- Strong clinical progress and $345M financing extend cash runway into 2029 for multiple Phase 2 trials.GLUEQ4 202517 Mar 2026
- Multiple phase II trials and new INDs planned in 2024, with strong data in NEK7 and GSPT1 programs.GLUETD Cowen 46th Annual Health Care Conference2 Mar 2026
- MRT-8102 achieved 85% CRP reduction, strong cytokine suppression, and favorable safety in Phase 1.GLUEStudy Result3 Feb 2026
- AI-driven molecular glue degraders advance in oncology and immunology with multiple INDs ahead.GLUEUBS Targeted Protein Degradation Day 20243 Feb 2026
- Multiple clinical catalysts ahead as molecular glue degrader programs advance in oncology and immunology.GLUE2024 Wells Fargo Healthcare Conference22 Jan 2026
- Broad pipeline advances with molecular glue degraders and a landmark Novartis immunology deal.GLUEJefferies London Healthcare Conference 202413 Jan 2026
Next Monte Rosa Therapeutic earnings date
Q1 20268 May, 2026
Monte Rosa Therapeutic
Next Monte Rosa Therapeutic earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage